Zobrazeno 1 - 10
of 257
pro vyhledávání: '"L, Gradowska"'
Autor:
Tim Grob, Mathijs A. Sanders, Christian M. Vonk, Franҫois G. Kavelaars, Melissa Rijken, Diana W. Hanekamp, Patrycja L. Gradowska, Jacqueline Cloos, Yngvar Fløisand, Marinus van Marwijk Kooy, Markus G. Manz, Gert J. Ossenkoppele, Lidwine W. Tick, Violaine Havelange, Bob Löwenberg, Mojca Jongen-Lavrencic, Peter J.M. Valk
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(4):JCO2200715, 756-765. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(4), 756-765. American Society of Clinical Oncology
Grob, T, Sanders, M A, Vonk, C M, Kavelaars, F G, Rijken, M, Hanekamp, D W, Gradowska, P L, Cloos, J, Fløisand, Y, van Marwijk Kooy, M, Manz, M G, Ossenkoppele, G J, Tick, L W, Havelange, V, Löwenberg, B, Jongen-Lavrencic, M & Valk, P J M 2023, ' Prognostic Value of FLT3-Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 41, no. 4, pp. 756-765 . https://doi.org/10.1200/JCO.22.00715, https://doi.org/10.1200/JCO.22.00715
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(4), 756-765. American Society of Clinical Oncology
Grob, T, Sanders, M A, Vonk, C M, Kavelaars, F G, Rijken, M, Hanekamp, D W, Gradowska, P L, Cloos, J, Fløisand, Y, van Marwijk Kooy, M, Manz, M G, Ossenkoppele, G J, Tick, L W, Havelange, V, Löwenberg, B, Jongen-Lavrencic, M & Valk, P J M 2023, ' Prognostic Value of FLT3-Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 41, no. 4, pp. 756-765 . https://doi.org/10.1200/JCO.22.00715, https://doi.org/10.1200/JCO.22.00715
PURPOSE The applicability of FLT3-internal tandem duplications ( FLT3-ITD) for assessing measurable residual disease (MRD) in acute myeloid leukemia (AML) in complete remission (CR) has been hampered by patient-specific duplications and potential ins
Autor:
Tim Grob, Adil S. A. Al Hinai, Mathijs A. Sanders, François G. Kavelaars, Melissa Rijken, Patrycja L. Gradowska, Bart J. Biemond, Dimitri A. Breems, Johan Maertens, Marinus van Marwijk Kooy, Thomas Pabst, Okke de Weerdt, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht, Gerwin A. Huls, Jan J. Cornelissen, H. Berna Beverloo, Bob Löwenberg, Mojca Jongen-Lavrencic, Peter J. M. Valk
Publikováno v:
Blood, 139(15), 2347-2354. AMER SOC HEMATOLOGY
Blood, 139(15), 2347-2354. American Society of Hematology
Grob, T, Al Hinai, A S A, Sanders, M A, Kavelaars, F G, Rijken, M, Gradowska, P L, Biemond, B J, Breems, D A, Maertens, J, van Marwijk Kooy, M, Pabst, T, de Weerdt, O, Ossenkoppele, G J, van de Loosdrecht, A A, Huls, G A, Cornelissen, J J, Beverloo, H B, Löwenberg, B, Jongen-Lavrencic, M & Valk, P J M 2022, ' Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome ', Blood, vol. 139, no. 15, pp. 2347-2354 . https://doi.org/10.1182/blood.2021014472
Blood, 139(15), 2347-2354. American Society of Hematology
Grob, T, Al Hinai, A S A, Sanders, M A, Kavelaars, F G, Rijken, M, Gradowska, P L, Biemond, B J, Breems, D A, Maertens, J, van Marwijk Kooy, M, Pabst, T, de Weerdt, O, Ossenkoppele, G J, van de Loosdrecht, A A, Huls, G A, Cornelissen, J J, Beverloo, H B, Löwenberg, B, Jongen-Lavrencic, M & Valk, P J M 2022, ' Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome ', Blood, vol. 139, no. 15, pp. 2347-2354 . https://doi.org/10.1182/blood.2021014472
Substantial heterogeneity within mutant TP53 acute myeloid leukemia (AML) and myelodysplastic syndrome with excess of blast (MDS-EB) precludes the exact assessment of prognostic impact for individual patients. We performed in-depth clinical and molec
Autor:
Nanda Horeweg, Prachi Mittal, Patrycja L. Gradowska, Ingrid Boere, Remi A. Nout, Supriya Chopra
Publikováno v:
Critical Reviews in Oncology/Hematology, 172. ELSEVIER SCIENCE INC
We investigated whether the addition of adjuvant chemotherapy to chemoradiation improves overall survival (OS) and progression-free survival (PFS) by conducting a systematic review and meta-analysis. Systematic searches in the databases of PubMed, Em
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2681e3a0a9e0a3cf6c94a56b50f545a
https://doi.org/10.1016/j.critrevonc.2022.103638
https://doi.org/10.1016/j.critrevonc.2022.103638
Autor:
François G. Kavelaars, Elvira Verhoef, Bianca Venniker-Punt, Peter J. M. Valk, Christian M. Vonk, Pauline A. Merle, Zinia J. Kwidama, Jacqueline Cloos, Patrycja L Gradowska, Jeroen Janssen, David G. J. Cucchi, Bob Löwenberg, Melissa Rijken
Publikováno v:
Cucchi, D G, Vonk, C M, Rijken, M, Kavelaars, F, Merle, P, Verhoef, E, Venniker-Punt, B, Kwidama, Z J, Gradowska, P, Löwenberg, B, Janssen, J J W M, Cloos, J & Valk, P J M 2021, ' DNA vs cDNA FLT3-ITD allelic ratio and length measurements in adult acute myeloid leukemia ', BLOOD ADVANCES, vol. 5, no. 21, pp. 4476-4479 . https://doi.org/10.1182/bloodadvances.2021004980
Blood Advances
Blood advances, 5(21), 4476-4479. American Society of Hematology
BLOOD ADVANCES, 5(21), 4476-4479. American Society of Hematology
Blood Advances
Blood advances, 5(21), 4476-4479. American Society of Hematology
BLOOD ADVANCES, 5(21), 4476-4479. American Society of Hematology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28b787f38dc96d2345cc2e518086b31a
https://research.vumc.nl/en/publications/0a7b0550-67cd-4a96-a66d-a7a25142ae3d
https://research.vumc.nl/en/publications/0a7b0550-67cd-4a96-a66d-a7a25142ae3d
Autor:
Patrycja L Gradowska, Remi A. Nout, Ingrid A. Boere, Nanda Horeweg, Supriya Chopra, Prachi Mittal
Publikováno v:
Cancers, 13(8). MDPI
Cancers
Cancers, Vol 13, Iss 1880, p 1880 (2021)
Cancers
Cancers, Vol 13, Iss 1880, p 1880 (2021)
Simple Summary The standard of care for locally advanced cervical cancer is chemoradiation and brachytherapy. The addition of adjuvant systemic treatment may improve overall survival. A systematic review and meta-analysis were conducted to summarize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b75d789e61a8be8cc0247da1e331535e
https://hdl.handle.net/1887/3278810
https://hdl.handle.net/1887/3278810
Autor:
Patrycja L Gradowska, Tim Grob, Carlos Graux, Diana Hanekamp, Violaine Havelange, Adil Al Hinai, François G. Kavelaars, Mojca Jongen-Lavrencic, Marinus van Marwijk Kooy, Annelieke Zeilemaker, Bart J. Biemond, Bob Löwenberg, Mathijs A. Sanders, Markus G. Manz, Jakob Passweg, Rosa Meijer, Gerrit Jan Schuurhuis, Jacqueline Cloos, Gert J. Ossenkoppele, Peter J. M. Valk, Claudia A.J. Erpelinck-Verschueren, Thomas Pabst
Publikováno v:
Jongen-Lavrencic, Mojca; Grob, Tim; Hanekamp, Diana; Kavelaars, François G; Al Hinai, Adil; Zeilemaker, Annelieke; Erpelinck-Verschueren, Claudia A J; Gradowska, Patrycja L; Meijer, Rosa; Cloos, Jacqueline; Biemond, Bart J; Graux, Carlos; van Marwijk Kooy, Marinus; Manz, Markus G; Pabst Müller, Thomas Niklaus; Passweg, Jakob R; Havelange, Violaine; Ossenkoppele, Gert J; Sanders, Mathijs A; Schuurhuis, Gerrit J; ... (2018). Molecular Minimal Residual Disease in Acute Myeloid Leukemia. New England journal of medicine NEJM, 378(13), pp. 1189-1199. Massachusetts Medical Society MMS 10.1056/NEJMoa1716863
New England Journal of Medicine, 378(13), 1189-1199. Massachussetts Medical Society
New England journal of medicine, 378(13), 1189-1199. Massachussetts Medical Society
Jongen-Lavrencic, M, Grob, T, Hanekamp, D, Kavelaars, F G, Al Hinai, A, Zeilemaker, A, Erpelinck-Verschueren, C A J, Gradowska, P L, Meijer, R, Cloos, J, Biemond, B J, Graux, C, van Marwijk Kooy, M, Manz, M G, Pabst, T, Passweg, J R, Havelange, V, Ossenkoppele, G J, Sanders, M A, Schuurhuis, G J, Löwenberg, B & Valk, P J M 2018, ' Molecular Minimal Residual Disease in Acute Myeloid Leukemia ', New England Journal of Medicine, vol. 378, no. 13, pp. 1189-1199 . https://doi.org/10.1056/NEJMoa1716863
The New England journal of medicine, Vol. 378, no. 13, p. 1189-1199 (2018)
New England Journal of Medicine, 378(13), 1189-1199. Massachussetts Medical Society
New England journal of medicine, 378(13), 1189-1199. Massachussetts Medical Society
Jongen-Lavrencic, M, Grob, T, Hanekamp, D, Kavelaars, F G, Al Hinai, A, Zeilemaker, A, Erpelinck-Verschueren, C A J, Gradowska, P L, Meijer, R, Cloos, J, Biemond, B J, Graux, C, van Marwijk Kooy, M, Manz, M G, Pabst, T, Passweg, J R, Havelange, V, Ossenkoppele, G J, Sanders, M A, Schuurhuis, G J, Löwenberg, B & Valk, P J M 2018, ' Molecular Minimal Residual Disease in Acute Myeloid Leukemia ', New England Journal of Medicine, vol. 378, no. 13, pp. 1189-1199 . https://doi.org/10.1056/NEJMoa1716863
The New England journal of medicine, Vol. 378, no. 13, p. 1189-1199 (2018)
BACKGROUND: Patients with acute myeloid leukemia (AML) often reach complete remission, but relapse rates remain high. Next-generation sequencing enables the detection of molecular minimal residual disease in virtually every patient, but its clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2115adb936d578bc0d5a90c366f4ee25
Autor:
P. L. Gradowska, Roger M. Cooke
Publikováno v:
Computational Statistics & Data Analysis. 56:2288-2302
A new estimation procedure for the Cox proportional hazards model is introduced. The method proposed employs the sample covariance matrix of model covariates and alternates between estimating the baseline cumulative hazard function and estimating mod
Autor:
B. Kamiñska, Mieczyslaw Lao, Joanna Pazik, L Gradowska, Leszek Paczek, T. Cieciura, Wojciech Rowinski, E Nowacka-Cieciura
Publikováno v:
Transplant International. 13:S68-S72
Mycophenolate mofetil (MMF) is a powerful immunosuppressive drug with established efficacy and safety. The search for a less expensive immunosuppressive protocol has led to an open randomised clinical trial of conversion from MMF to azathioprine (Aza
Autor:
Magdalena Durlik, Krzysztof Mucha, Jacek Szmidt, Sławomir Nazarewski, Bartosz Foroncewicz, L Gradowska, J Wałaszewski, D. Lewandowska, Jacek Pliszczyński, Leszek Paczek, A Krawczyk, Joanna Pazik
Publikováno v:
Transplantation Proceedings. 35:2176-2178
Objectives The aim of this retrospective study was to assess the incidence of acute rejection episodes (AR), diabetes mellitus (DM), and serum creatinine (SCr) among renal transplant recipients treated with tacrolimus (Tac), steroids (S), and mycophe
Autor:
L, Paczek, J, Pazik, M, Teschner, R M, Schaefer, W, Rowinski, J, Szmidt, M, Lao, K, Abgarowicz, L, Gradowska, M, Morzycka-Michalik, A, Heidland
Publikováno v:
Transplant International. 7:311-313
The major reason for late graft losses is chronic rejection. Recently, a large number of studies have indicated that proteolytic enzymes play an important role as mediators of glomerular injury. The cysteine proteinases cathepsins B and L degrade str